Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

204 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
De Marchis GM, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler NG, Mattle HP, Mueller B, Christ-Crain M, Arnold M, Katan M. De Marchis GM, et al. Among authors: morgenthaler ng. Stroke. 2014 Oct;45(10):2918-23. doi: 10.1161/STROKEAHA.114.005584. Epub 2014 Aug 28. Stroke. 2014. PMID: 25169950 Clinical Trial.
Copeptin: clinical use of a new biomarker.
Morgenthaler NG, Struck J, Jochberger S, Dünser MW. Morgenthaler NG, et al. Trends Endocrinol Metab. 2008 Mar;19(2):43-9. doi: 10.1016/j.tem.2007.11.001. Trends Endocrinol Metab. 2008. PMID: 18291667
Reduced serum selenoprotein P concentrations in German prostate cancer patients.
Meyer HA, Hollenbach B, Stephan C, Endermann T, Morgenthaler NG, Cammann H, Köhrle J, Jung K, Schomburg L. Meyer HA, et al. Among authors: morgenthaler ng. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2386-90. doi: 10.1158/1055-9965.EPI-09-0262. Epub 2009 Aug 18. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19690186
204 results